Women’s Health – The Untapped Opportunity – Asrar Qureshi’s Blog Post #1062

Asrar Qureshi’s blog discusses the underfunding and lack of research in women’s health, highlighting that major pharmaceutical companies often overlook women’s unique health needs. It emphasizes the opportunity for innovation by addressing sex-specific differences in drug development, which could greatly improve women’s health outcomes and unlock significant economic potential.
Share
View Post

Expected Changes for Contract Research Organizations – Asrar Qureshi’s Blog Post #1040

This blog post by Asrar Qureshi discusses the role of Contract Research Organizations (CROs) in pharmaceutical development, including their services like clinical trial management and regulatory support. It highlights challenges and evolving trends in the industry, such as technology integration and changing sponsor needs, emphasizing the importance of adaptation for CROs’ future success.
Share
View Post

Pharma & the Future: Powered by Partnership & Patient Experience – Asrar Qureshi’s Blog Post 993

This blogpost provides a summary of a new Whitepaper on patient engagement within the pharmaceutical industry. It discusses the shift towards prioritizing patients, driven by global and local initiatives, and the challenges and opportunities in measuring the impact of patient engagement. It also highlights the importance of strategic partnerships and technology in driving the industry’s future success.
Share